Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 11/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | PTAFR | P25105 | 1/20 | 0.31 |
| ▸ | HTR2B | P41595 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19116664 | 0.93 | HTT (0.39) | GRM2HTTMAPK1ALDH1A1 | |
| SCHEMBL19722541 | 0.87 | HTT (0.43) | HTTMAPK1ALDH1A1POLB | |
| SCHEMBL22898911 | 0.87 | HTT (0.34) | HTTMAPK1 | |
| SCHEMBL22899088 | 0.84 | RGS4 (0.42) | HTT | |
| SCHEMBL22899026 | 0.83 | HTT (0.47) | HTTMAPK1ALDH1A1POLB | |
| SCHEMBL18927853 | 0.82 | RGS4 (0.41) | HTTALDH1A1 | |
| SCHEMBL295471 | 0.79 | HTT (0.46) | HTTMAPK1ALDH1A1 | |
| SCHEMBL11187717 | 0.77 | HTT (0.42) | HTTMAPK1ALDH1A1POLB | |
| SCHEMBL19722545 | 0.76 | CYP3A4 (0.55) | HTTMAPK1ALDH1A1 | |
| SCHEMBL15693098 | 0.74 | GRM2 (0.39) | GRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210020991-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2021-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210020991-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY | SLC9B2, SLC9A1, SLC9A2 | GRM2 2916/4885HTT 4397/4885MAPK1 556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.